Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Cao Y"'
Artemisinin enhances the anti-tumor immune response in 4T1 breast cancer cells in vitro and in vivo.
Autor:
Cao Y; Laboratory of Precision Oncology, China Medial University School of Pharmacy, Shenyang, Liaoning, China; Department of Surgical Oncology and Breast Surgery, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning, China. Electronic address: caoyu@cmu.edu.cn., Feng YH; Department of Laboratory Medicine, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning, China., Gao LW; Department of Radiation Oncology, China Japan Friendship Hospital, Beijing, China., Li XY; Department of Surgical Oncology and Breast Surgery, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning, China., Jin QX; Department of Surgical Oncology and Breast Surgery, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning, China; Department of Breast Surgery, Liaoning Cancer Hospital, Shenyang, Liaoning, China., Wang YY; Department of Surgical Oncology and Breast Surgery, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning, China; Department of Breast Surgery, Liaoning Cancer Hospital, Shenyang, Liaoning, China., Xu YY; Department of Surgical Oncology and Breast Surgery, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning, China., Jin F; Department of Surgical Oncology and Breast Surgery, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning, China., Lu SL; Laboratory of Precision Oncology, China Medial University School of Pharmacy, Shenyang, Liaoning, China; Department of Otolaryngology, University of Colorado School of Medicine, Aurora, CO 80045, USA. Electronic address: shi-long.lu@ucdenver.edu., Wei MJ; Laboratory of Precision Oncology, China Medial University School of Pharmacy, Shenyang, Liaoning, China. Electronic address: weiminjiecmu@163.com.
Publikováno v:
International immunopharmacology [Int Immunopharmacol] 2019 May; Vol. 70, pp. 110-116. Date of Electronic Publication: 2019 Feb 21.
Autor:
Zhang Y; Department of Laboratory Medicine, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning 110001, China., Cao Y; Department of Surgical Oncology and Breast Surgery, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning 110001, China., Sun X; Department of Immunology, College of Basic Medical Sciences, China Medical University, Shenyang, Liaoning 110122, China., Feng Y; Department of Medical Examination Center, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning 110001, China., Du Y; Department of Immunology, College of Basic Medical Sciences, China Medical University, Shenyang, Liaoning 110122, China., Liu F; Department of Immunology, College of Basic Medical Sciences, China Medical University, Shenyang, Liaoning 110122, China., Yu C; Department of Laboratory Medicine, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning 110001, China., Jin F; Department of Surgical Oncology and Breast Surgery, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning 110001, China. Electronic address: jinfeng66cn@hotmail.com.
Publikováno v:
International immunopharmacology [Int Immunopharmacol] 2017 Jan; Vol. 42, pp. 100-107. Date of Electronic Publication: 2016 Nov 29.